Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer

Immunotherapy with checkpoint inhibitors has prompted a major change not only in cancer treatment but also in medical imaging. In parallel with the implementation of new drugs modulating the immune system, new response criteria have been developed, aiming to overcome clinical drawbacks related to th...

Descripción completa

Detalles Bibliográficos
Autor principal: Lopci, Egesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584484/
https://www.ncbi.nlm.nih.gov/pubmed/34768681
http://dx.doi.org/10.3390/jcm10215160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584484/
https://www.ncbi.nlm.nih.gov/pubmed/34768681
http://dx.doi.org/10.3390/jcm10215160

Ejemplares similares